Annual accounts receivable:
$16.65M+$15.37M(+1197.74%)Summary
- As of today (July 1, 2025), CYTK annual accounts receivable is $16.65 million, with the most recent change of +$15.37 million (+1197.74%) on December 31, 2024.
- During the last 3 years, CYTK annual accounts receivable has fallen by -$35.17 million (-67.87%).
- CYTK annual accounts receivable is now -67.87% below its all-time high of $51.82 million, reached on December 31, 2021.
Performance
CYTK Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$2.01M-$14.64M(-87.92%)Summary
- As of today (July 1, 2025), CYTK quarterly accounts receivable is $2.01 million, with the most recent change of -$14.64 million (-87.92%) on March 1, 2025.
- Over the past year, CYTK quarterly accounts receivable has increased by +$1.18 million (+141.25%).
- CYTK quarterly accounts receivable is now -97.00% below its all-time high of $67.00 million, reached on September 30, 2016.
Performance
CYTK Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CYTK Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1197.7% | +141.3% |
| 3 y3 years | -67.9% | -66.8% |
| 5 y5 years | +222.5% | -25.6% |
CYTK Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.9% | >+9999.0% | -87.9% | >+9999.0% |
| 5 y | 5-year | -67.9% | >+9999.0% | -96.1% | >+9999.0% |
| alltime | all time | -67.9% | >+9999.0% | -97.0% | >+9999.0% |
CYTK Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $2.01M(-87.9%) |
| Dec 2024 | $16.65M(+1197.7%) | $16.65M(+6723.8%) |
| Sep 2024 | - | $244.00K(>+9900.0%) |
| Jun 2024 | - | $0.00(-100.0%) |
| Mar 2024 | - | $834.00K(-35.0%) |
| Dec 2023 | $1.28M(+772.8%) | $1.28M(-48.7%) |
| Sep 2023 | - | $2.50M(+153.7%) |
| Jun 2023 | - | $985.00K(-2.1%) |
| Mar 2023 | - | $1.01M(+584.4%) |
| Dec 2022 | $147.00K(-99.7%) | $147.00K(-93.6%) |
| Sep 2022 | - | $2.29M(+16.3%) |
| Jun 2022 | - | $1.97M(-67.4%) |
| Mar 2022 | - | $6.06M(-88.3%) |
| Dec 2021 | $51.82M(+1072.4%) | $51.82M(+7946.4%) |
| Sep 2021 | - | $644.00K(-76.2%) |
| Jun 2021 | - | $2.70M(-40.2%) |
| Mar 2021 | - | $4.51M(+2.1%) |
| Dec 2020 | $4.42M(-14.4%) | $4.42M(-11.0%) |
| Sep 2020 | - | $4.96M(+120.3%) |
| Jun 2020 | - | $2.25M(-16.6%) |
| Mar 2020 | - | $2.70M(-47.6%) |
| Dec 2019 | $5.16M(+131.4%) | $5.16M(-21.5%) |
| Sep 2019 | - | $6.58M(-26.9%) |
| Jun 2019 | - | $8.99M(+115.9%) |
| Mar 2019 | - | $4.17M(+86.7%) |
| Dec 2018 | $2.23M(+100.6%) | $2.23M(-75.6%) |
| Sep 2018 | - | $9.16M(+3779.7%) |
| Jun 2018 | - | $236.00K(+537.8%) |
| Mar 2018 | - | $37.00K(-96.7%) |
| Dec 2017 | $1.11M(+4533.3%) | $1.11M(-88.9%) |
| Sep 2017 | - | $10.00M(>+9900.0%) |
| Jun 2017 | - | $0.00(-100.0%) |
| Mar 2017 | - | $910.00K(+3691.7%) |
| Dec 2016 | $24.00K(+100.0%) | $24.00K(-100.0%) |
| Sep 2016 | - | $67.00M(>+9900.0%) |
| Jun 2016 | - | $26.00K(>+9900.0%) |
| Mar 2016 | - | $0.00(-100.0%) |
| Dec 2015 | $12.00K(-100.0%) | $12.00K(-74.5%) |
| Sep 2015 | - | $47.00K(+1075.0%) |
| Jun 2015 | - | $4000.00(-99.6%) |
| Mar 2015 | - | $970.00K(-97.9%) |
| Dec 2014 | $46.65M | $46.65M(+3816.5%) |
| Sep 2014 | - | $1.19M(+273.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $319.00K(-84.9%) |
| Mar 2014 | - | $2.12M(>+9900.0%) |
| Dec 2013 | $5000.00(+25.0%) | $5000.00(>+9900.0%) |
| Sep 2013 | - | $0.00(-100.0%) |
| Jun 2013 | - | $16.00M(+4778.0%) |
| Mar 2013 | - | $328.00K(+8100.0%) |
| Dec 2012 | $4000.00(-71.4%) | $4000.00(>+9900.0%) |
| Sep 2012 | - | $0.00(-100.0%) |
| Jun 2012 | - | $3000.00(-96.4%) |
| Mar 2012 | - | $83.00K(+492.9%) |
| Dec 2011 | $14.00K(-69.6%) | $14.00K(-87.9%) |
| Sep 2011 | - | $116.00K(+329.6%) |
| Jun 2011 | - | $27.00K(-20.6%) |
| Mar 2011 | - | $34.00K(-26.1%) |
| Dec 2010 | $46.00K(-74.4%) | $46.00K(-82.4%) |
| Sep 2010 | - | $262.00K(+24.2%) |
| Jun 2010 | - | $211.00K(+1818.2%) |
| Mar 2010 | - | $11.00K(-93.9%) |
| Dec 2009 | $180.00K(-18.6%) | $180.00K(-96.0%) |
| Sep 2009 | - | $4.54M(+770.5%) |
| Jun 2009 | - | $522.00K(+7357.1%) |
| Mar 2009 | - | $7000.00(-96.8%) |
| Dec 2008 | $221.00K(+154.0%) | $221.00K(+220.3%) |
| Sep 2008 | - | $69.00K(+15.0%) |
| Jun 2008 | - | $60.00K(+3.4%) |
| Mar 2008 | - | $58.00K(-33.3%) |
| Dec 2007 | $87.00K(-99.8%) | $87.00K(-33.1%) |
| Sep 2007 | - | $130.00K(+100.0%) |
| Jun 2007 | - | $65.00K(-51.1%) |
| Mar 2007 | - | $133.00K(-99.7%) |
| Dec 2006 | $42.07M(+7204.0%) | $42.07M(>+9900.0%) |
| Sep 2006 | - | $63.00K(-11.3%) |
| Jun 2006 | - | $71.00K(+42.0%) |
| Mar 2006 | - | $50.00K(-91.3%) |
| Dec 2005 | $576.00K(+986.8%) | $576.00K(-41.5%) |
| Sep 2005 | - | $984.00K(+366.4%) |
| Jun 2005 | - | $211.00K(+61.1%) |
| Mar 2005 | - | $131.00K(+147.2%) |
| Dec 2004 | $53.00K(-79.8%) | $53.00K(-70.9%) |
| Sep 2004 | - | $182.00K(-8.1%) |
| Jun 2004 | - | $198.00K(-2.9%) |
| Mar 2004 | - | $204.00K(-22.4%) |
| Dec 2003 | $263.00K(+1543.8%) | $263.00K |
| Dec 2002 | $16.00K | - |
FAQ
- What is Cytokinetics Incorporated annual accounts receivable?
- What is the all time high annual accounts receivable for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual accounts receivable year-on-year change?
- What is Cytokinetics Incorporated quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly accounts receivable year-on-year change?
What is Cytokinetics Incorporated annual accounts receivable?
The current annual accounts receivable of CYTK is $16.65M
What is the all time high annual accounts receivable for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual accounts receivable is $51.82M
What is Cytokinetics Incorporated annual accounts receivable year-on-year change?
Over the past year, CYTK annual accounts receivable has changed by +$15.37M (+1197.74%)
What is Cytokinetics Incorporated quarterly accounts receivable?
The current quarterly accounts receivable of CYTK is $2.01M
What is the all time high quarterly accounts receivable for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly accounts receivable is $67.00M
What is Cytokinetics Incorporated quarterly accounts receivable year-on-year change?
Over the past year, CYTK quarterly accounts receivable has changed by +$1.18M (+141.25%)